618 related articles for article (PubMed ID: 29473763)
1. Statin-induced myalgia and myositis: an update on pathogenesis and clinical recommendations.
Selva-O'Callaghan A; Alvarado-Cardenas M; Pinal-Fernández I; Trallero-Araguás E; Milisenda JC; Martínez MÁ; Marín A; Labrador-Horrillo M; Juárez C; Grau-Junyent JM
Expert Rev Clin Immunol; 2018 Mar; 14(3):215-224. PubMed ID: 29473763
[TBL] [Abstract][Full Text] [Related]
2. Statins and myositis: the role of anti-HMGCR antibodies.
Selva-O'Callaghan A; Alvarado-Cardenas M; Marin A; Pinal-Fernandez I
Expert Rev Clin Immunol; 2015; 11(12):1277-9. PubMed ID: 26492593
[TBL] [Abstract][Full Text] [Related]
3. Autoimmune necrotising myopathy and HMGCR antibodies.
Karunaratne K; Amiras D; Pickering MC; Hofer M; Viegas S
Pract Neurol; 2018 Apr; 18(2):151-155. PubMed ID: 29439058
[TBL] [Abstract][Full Text] [Related]
4. Statin-naïve anti-HMGCR antibody-mediated necrotizing myopathy in China.
Jiao Y; Cai S; Lin J; Zhu W; Xi J; Li J; Yue D; Zhang T; Qiao K; Wang Y; Zhao C; Lu J
J Clin Neurosci; 2018 Nov; 57():13-19. PubMed ID: 30205933
[TBL] [Abstract][Full Text] [Related]
5. Autoantibodies against 3-hydroxy-3-methylglutaryl-coenzyme A reductase in patients with statin-associated autoimmune myopathy.
Mammen AL; Chung T; Christopher-Stine L; Rosen P; Rosen A; Doering KR; Casciola-Rosen LA
Arthritis Rheum; 2011 Mar; 63(3):713-21. PubMed ID: 21360500
[TBL] [Abstract][Full Text] [Related]
6. Anti-HMGCR antibodies as a biomarker for immune-mediated necrotizing myopathies: A history of statins and experience from a large international multi-center study.
Musset L; Allenbach Y; Benveniste O; Boyer O; Bossuyt X; Bentow C; Phillips J; Mammen A; Van Damme P; Westhovens R; Ghirardello A; Doria A; Choi MY; Fritzler MJ; Schmeling H; Muro Y; García-De La Torre I; Ortiz-Villalvazo MA; Bizzaro N; Infantino M; Imbastaro T; Peng Q; Wang G; Vencovský J; Klein M; Krystufkova O; Franceschini F; Fredi M; Hue S; Belmondo T; Danko K; Mahler M
Autoimmun Rev; 2016 Oct; 15(10):983-93. PubMed ID: 27491568
[TBL] [Abstract][Full Text] [Related]
7. Anti-HMGCR antibodies demonstrate high diagnostic value in the diagnosis of immune-mediated necrotizing myopathy following statin exposure.
Shovman O; Gilburd B; Chayat C; Lazar AD; Amital H; Blank M; Bentow C; Mahler M; Shoenfeld Y
Immunol Res; 2017 Feb; 65(1):276-281. PubMed ID: 27618830
[TBL] [Abstract][Full Text] [Related]
8. Statins and myotoxic effects associated with anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase autoantibodies: an observational study in Japan.
Watanabe Y; Suzuki S; Nishimura H; Murata KY; Kurashige T; Ikawa M; Asahi M; Konishi H; Mitsuma S; Kawabata S; Suzuki N; Nishino I
Medicine (Baltimore); 2015 Jan; 94(4):e416. PubMed ID: 25634171
[TBL] [Abstract][Full Text] [Related]
9. Clinical and genetic associations of autoantibodies to 3-hydroxy-3-methyl-glutaryl-coenzyme a reductase in patients with immune-mediated myositis and necrotizing myopathy.
Limaye V; Bundell C; Hollingsworth P; Rojana-Udomsart A; Mastaglia F; Blumbergs P; Lester S
Muscle Nerve; 2015 Aug; 52(2):196-203. PubMed ID: 25521389
[TBL] [Abstract][Full Text] [Related]
10. Statin-associated autoimmune myopathy and anti-HMGCR autoantibodies.
Mohassel P; Mammen AL
Muscle Nerve; 2013 Oct; 48(4):477-83. PubMed ID: 23519993
[TBL] [Abstract][Full Text] [Related]
11. Proposed cut-off for reactivity of anti-HMGCR and anti-SRP antibodies in patients statin-exposed and statin-unexposed.
Carvalho AAS; Silva VGD; Vieira TF; Delgado PO; Corazini R; Feder D; Fonseca FLA
Medicine (Baltimore); 2018 Aug; 97(35):e11858. PubMed ID: 30170376
[TBL] [Abstract][Full Text] [Related]
12. Statin-induced necrotizing myositis - a discrete autoimmune entity within the "statin-induced myopathy spectrum".
Hamann PD; Cooper RG; McHugh NJ; Chinoy H
Autoimmun Rev; 2013 Oct; 12(12):1177-81. PubMed ID: 23851103
[TBL] [Abstract][Full Text] [Related]
13. Immune-mediated myopathy related to anti 3-hydroxy-3-methylglutaryl-coenzyme A reductase antibodies as an emerging cause of necrotizing myopathy induced by statins.
Lahaye C; Beaufrére AM; Boyer O; Drouot L; Soubrier M; Tournadre A
Joint Bone Spine; 2014 Jan; 81(1):79-82. PubMed ID: 23953224
[TBL] [Abstract][Full Text] [Related]
14. Necrotizing Autoimmune myopathy: A case report on statin induced rhabdomyolysis requiring immunosuppressive therapy.
Kunwar S; Parekh JD; Chilukuri RS; Andukuri VA
Drug Discov Ther; 2018; 12(5):315-317. PubMed ID: 30464165
[TBL] [Abstract][Full Text] [Related]
15. Pediatric necrotizing myopathy associated with anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase antibodies.
Liang WC; Uruha A; Suzuki S; Murakami N; Takeshita E; Chen WZ; Jong YJ; Endo Y; Komaki H; Fujii T; Kawano Y; Mori-Yoshimura M; Oya Y; Xi J; Zhu W; Zhao C; Watanabe Y; Ikemoto K; Nishikawa A; Hamanaka K; Mitsuhashi S; Suzuki N; Nishino I
Rheumatology (Oxford); 2017 Feb; 56(2):287-293. PubMed ID: 27818386
[TBL] [Abstract][Full Text] [Related]
16. Anti-HMGCR Myopathy.
Mohassel P; Mammen AL
J Neuromuscul Dis; 2018; 5(1):11-20. PubMed ID: 29480216
[TBL] [Abstract][Full Text] [Related]
17. Anti-HMGCR antibodies and asymptomatic hyperCKemia. A case report.
Torri F; Ali G; Chico L; Siciliano G; Ricci G
Acta Myol; 2021 Jun; 40(2):105-108. PubMed ID: 34355128
[TBL] [Abstract][Full Text] [Related]
18. [Dermatomyositis-like syndrome revealing statin-induced necrotizing autoimmune myopathy with anti-HMGCR antibodies].
Merlant M; Fite C; Kottler D; Maisonobe L; Dossier A; Deschamps L; Descamps V
Ann Dermatol Venereol; 2019 Sep; 146(8-9):550-556. PubMed ID: 30929872
[TBL] [Abstract][Full Text] [Related]
19. Statin-associated autoimmune myopathy: A distinct new IFL pattern can increase the rate of HMGCR antibody detection by clinical laboratories.
Alvarado-Cardenas M; Marin-Sánchez A; Martínez MA; Martínez-Martínez L; Pinal-Fernandez I; Labrador-Horrillo M; Balada E; Mundet-Tuduri X; Gonzalez-Mera L; Casademont J; Acebes EM; Moreno PJ; Juarez C; Grau-Junyent JM; Pujol-Borrell R; Selva-O'Callaghan A
Autoimmun Rev; 2016 Dec; 15(12):1161-1166. PubMed ID: 27640317
[TBL] [Abstract][Full Text] [Related]
20. Immune-mediated necrotizing myopathy associated with statins: history and recent developments.
Tiniakou E; Christopher-Stine L
Curr Opin Rheumatol; 2017 Nov; 29(6):604-611. PubMed ID: 28857949
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
